tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

HK:2105 Stock Latest News

Laekna, Inc. Advances LAE103 with FDA Application
Company AnnouncementsLaekna, Inc. Advances LAE103 with FDA Application
27d ago
2105
Laekna, Inc. Unveils Promising Study Results at ADA 2025
PremiumCompany Announcements
Laekna, Inc. Unveils Promising Study Results at ADA 2025
1M ago
2105
Laekna, Inc. Successfully Concludes Annual General Meeting with All Resolutions Passed
PremiumCompany Announcements
Laekna, Inc. Successfully Concludes Annual General Meeting with All Resolutions Passed
2M ago
2105
Laekna, Inc. Announces Annual General Meeting and Key Resolutions
PremiumCompany Announcements
Laekna, Inc. Announces Annual General Meeting and Key Resolutions
3M ago
2105
Laekna, Inc. Grants 11.46 Million RSUs to Boost Executive and Employee Engagement
PremiumCompany Announcements
Laekna, Inc. Grants 11.46 Million RSUs to Boost Executive and Employee Engagement
3M ago
2105
Laekna, Inc. Advances Obesity Drug LAE102 with U.S. FDA Submission
PremiumCompany AnnouncementsLaekna, Inc. Advances Obesity Drug LAE102 with U.S. FDA Submission
4M ago
2105
Laekna, Inc. Advances Obesity Treatment with LAE102 Study
Premium
Company Announcements
Laekna, Inc. Advances Obesity Treatment with LAE102 Study
4M ago
2105
Laekna, Inc. Schedules Board Meeting to Approve Annual Results
Premium
Company Announcements
Laekna, Inc. Schedules Board Meeting to Approve Annual Results
5M ago
2105
Laekna Completes Phase I Study of Obesity Drug LAE102 with Positive Results
PremiumCompany Announcements
Laekna Completes Phase I Study of Obesity Drug LAE102 with Positive Results
7M ago
2105
Laekna Advances Obesity Treatment with LAE102 Trials
PremiumCompany Announcements
Laekna Advances Obesity Treatment with LAE102 Trials
8M ago
2105
Laekna, Inc. Advances LAE123 for Severe Diseases
PremiumCompany Announcements
Laekna, Inc. Advances LAE123 for Severe Diseases
8M ago
2105
Laekna, Inc. Raises HK$230 Million Through Share Placement
PremiumCompany Announcements
Laekna, Inc. Raises HK$230 Million Through Share Placement
8M ago
2105
Laekna, Inc. Announces Share Placement to Raise HK$230 Million
PremiumCompany AnnouncementsLaekna, Inc. Announces Share Placement to Raise HK$230 Million
8M ago
2105
Laekna Partners with Eli Lilly on Obesity Drug Development
Premium
Company Announcements
Laekna Partners with Eli Lilly on Obesity Drug Development
8M ago
2105
Laekna, Inc. Approves Key Executive Share Grants
Premium
Company Announcements
Laekna, Inc. Approves Key Executive Share Grants
9M ago
2105
Laekna, Inc. Advances Obesity Drug with New Trial Phase
PremiumCompany Announcements
Laekna, Inc. Advances Obesity Drug with New Trial Phase
9M ago
2105
Laekna, Inc. Schedules Key Meeting on Stock Grants
PremiumCompany Announcements
Laekna, Inc. Schedules Key Meeting on Stock Grants
10M ago
2105
Laekna Grants RSUs to Employees and Directors
PremiumCompany Announcements
Laekna Grants RSUs to Employees and Directors
11M ago
2105
Laekna, Inc. Accelerates Drug Development Trials
PremiumCompany Announcements
Laekna, Inc. Accelerates Drug Development Trials
12M ago
2105
Laekna, Inc. to Approve Mid-Year Financials
PremiumCompany AnnouncementsLaekna, Inc. to Approve Mid-Year Financials
12M ago
2105
Laekna Begins Clinical Trial for Obesity Drug
Premium
Company Announcements
Laekna Begins Clinical Trial for Obesity Drug
1y ago
2105
Laekna Shareholders Approve Key Resolutions
Premium
Company Announcements
Laekna Shareholders Approve Key Resolutions
1y ago
2105

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >